Supplement: MilliporeSigma Sees Opportunity in Continuous Processing
From the GEN Sounds of Science Podcast
Why CAR-T Therapies Don’t Work for Everyone Yet
Selecting the Best Type of T Cells for CAR-T May be Key to the Overall Efficacy of the Therapies
Cell-Centered: Scientists Embrace Cell-Replacement Therapy for Type 1 Diabetes
Forming Beta Cells from Stem Cells
GEN Roundup: Multiplex Immunoassays Bring the Array, Not the Disarray
Get Multiplex Immunoassay Advice from GEN's Expert Panel
For full access to this article login to GEN Select now.
Phenotypic Screens Take Atypical Course
Some New Screens Are Learning to Take Readings on the Fly, While Changing Course as Needed
- Drug discovery isn’t content with target-based screening. It isn’t even satisfied with the recent resurgence in phenotypic screening. No, it is holding out for something else, something even more informative—disease-relevant phenotypic assays. Such assays figured prominently at a recent conference organized by Cambridge Healthtech Institute. This conference, High-Content ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.